← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2002Last known activity
Mar 20, 2020
Timeline
2000s
- Jan 1, 2002
Dutch Childhood Oncology Group— Founded
Drugs by trial phase (29 distinct, 6 trials)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Blast Crisis
- Histiocytoma
- Histiocytoma, Benign Fibrous
- Histiocytoma, Malignant Fibrous
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Philadelphia Chromosome
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Rhabdomyosarcoma
- Sarcoma
Recent trials (7)
- NCT04258943CollaboratorPhase 1/Phase 2Mar 20, 2020
- NCT00550992Lead sponsorN/AJun 1, 2007
- NCT00379457CollaboratorPhase 3Jun 1, 2006
- NCT00379457Study chairPhase 3Jun 1, 2006
- NCT00334854CollaboratorPhase 3Mar 1, 2006
- NCT00186966Lead sponsorPhase 3Mar 1, 2002
- NCT00015873Lead sponsorPhase 3May 1, 1999
Details
- Founded
- The Hague, NL Jan 1, 2002
- Last known activity
- Mar 20, 2020